Pluristem (PSTI) - Cash Flow Conversion Efficiency

Latest as of March 2022: -0.235x

Based on the latest financial reports, Pluristem (PSTI) has a cash flow conversion efficiency ratio of -0.235x as of March 2022. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (ILA-9.42 Million ≈ $-25.26K USD) by net assets (ILA40.14 Million ≈ $107.62K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Pluristem - Cash Flow Conversion Efficiency Trend (2014–2021)

This chart illustrates how Pluristem's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Pluristem total liabilities for a breakdown of total debt and financial obligations.

Pluristem Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Pluristem ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Taiwan Alpha Electronic Co Ltd
TWO:6204
0.009x
Al-Salam Real Estate Investment Trust
KLSE:5269
0.068x
Hunya Foods Co Ltd
TW:1236
0.036x
Salcon Engineering Berhad
KLSE:8567
0.077x
Thitikorn Public Company Limited
BK:TK
0.001x
Fine Blanking & Tool Co Ltd
TWO:4535
0.036x
Dawonsys Co.Ltd
KQ:068240
0.103x
Song Shang Electronics Co Ltd
TWO:6156
-0.075x

Annual Cash Flow Conversion Efficiency for Pluristem (2014–2021)

The table below shows the annual cash flow conversion efficiency of Pluristem from 2014 to 2021. For the full company profile with market capitalisation and key ratios, see PSTI company net worth.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2021-06-30 ILA57.15 Million
≈ $153.22K
ILA-30.91 Million
≈ $-82.87K
-0.541x -15.07%
2020-06-30 ILA56.10 Million
≈ $150.40K
ILA-26.37 Million
≈ $-70.69K
-0.470x +65.18%
2019-06-30 ILA21.82 Million
≈ $58.50K
ILA-29.45 Million
≈ $-78.96K
-1.350x -79.97%
2018-06-30 ILA28.51 Million
≈ $76.43K
ILA-21.38 Million
≈ $-57.32K
-0.750x -4.98%
2017-06-30 ILA30.25 Million
≈ $81.10K
ILA-21.61 Million
≈ $-57.94K
-0.714x -47.17%
2016-06-30 ILA38.16 Million
≈ $102.29K
ILA-18.52 Million
≈ $-49.66K
-0.485x -36.98%
2015-06-30 ILA58.14 Million
≈ $155.88K
ILA-20.61 Million
≈ $-55.24K
-0.354x -15.14%
2014-06-30 ILA62.12 Million
≈ $166.55K
ILA-19.12 Million
≈ $-51.26K
-0.308x --

About Pluristem

TA:PSTI Israel Biotechnology & Medical Research
Market Cap
$65.47 Million
ILA24.42 Billion ILA
Market Cap Rank
#20955 Global
#284 in Israel
Share Price
ILA754.90
Change (1 day)
-4.71%
52-Week Range
ILA754.90 - ILA1900.00
All Time High
ILA72010.00
About

Pluri Inc., a biotechnology company, focuses on the development of placenta-based cell therapy product candidates for the treatment of multiple inflammatory, muscle injuries, and hematologic conditions. The company develops placental expanded (PLX) based cell therapy products, including PLX-PAD that is in Phase III clinical trials for the muscle recovery after surgery for hip fracture; in Phase I… Read more